Peptide library
Semaglutide: evidence profile
Approved product · Randomized evidence
Read each statement within its named product, route and evidence scope. The reading exercise below helps you examine a claim; it does not choose care.
Evidence record
- Product and route
- This entry covers subcutaneous Wegovy injection.
- Approval scope
- Wegovy injection: weight management in eligible adults.
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limits
- Check other products separately.
- Safety context
- Severe or persistent gastrointestinal symptoms: contact a clinician.
A reading exercise
Choose a result in a semaglutide discussion and cover its numerical value while leaving the heading visible. Write down the unit you expect the hidden value to have, then uncover the result and check your prediction against the accompanying definition. Pay particular attention to whether the quantity describes an amount, a proportion or a change from an earlier amount. Make a small label that could travel with the number if someone copied it elsewhere. Include the reference quantity needed to understand a change. If that label cannot be completed, identify the definition you need before comparing the result with another number.
Questions to take away
- What unit belongs beside this value when it is copied out of the table?
- Which reference quantity is needed to understand the reported change?
- Would the other number still be comparable after both labels were written out?
Sources
The dates below identify each source check. Publication of this page does not mean every source was checked again.